4

 · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the

  • Upload
    others

  • View
    8

  • Download
    0

Embed Size (px)

Citation preview

Page 1:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the
Page 2:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the
Page 3:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the
Page 4:  · after a microinjection (0.1—0.2 HI) of either AP V (an NMDA receptor antagonist) or NBQX (a non-NMDA receptor antagonist) into the nucleus prepositus hypo- glossi (NPH) of the